US 11339160
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted A61KA61K9/0014A61P
Quick answer
US patent 11339160 (Imidazole and triazole containing bicyclic compounds as JAK inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K9/0014, A61P, A61P1/00, A61P17/00